EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word (s): Quarterly / Interim Statement/Quarter Results SCHOTT Pharma records good start into fiscal year and confirms full year outlook 13.02.2025 / ...

A coalition of law enforcement agencies, led by a drug enforcement task force, has launched a campaign to reduce the presence ...

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to ...

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

In the first clinical trial of its kind, people taking semaglutide drank less alcohol, adding to its promise of fighting addiction.

Clinical decision support (CDS) aimed at reducing overuse of care in seniors does not yield durable changes in terms of ...

High cholesterol levels can impact anyone, even in the the modern day, and one four-time Olympian swears by one ready-made ...

ICON plc, a clinical research organization, expanded its portfolio of artificial intelligence (AI) tools that aim to deliver efficiencies across the clinical trial process, including study startup, ...

A mum holding her baby slipped £2,000 worth of drugs down an inmate's trousers while giving him a hug. Rebecca Gray was caught passing over the drugs parcel worth £2,000 at HMP Berwyn in Wrexham.

has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease, drugmaker Novo Nordisk said Tuesday. A Phase 3 clinical trial ...

Research published in the Alzheimer’s & Dementia medical journal has found that certain unrelated medications showed promise in reducing the risk of dementia, while others may require extra ...